{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:05:48Z","timestamp":1790863548834,"version":"4.1.0"},"reference-count":73,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100015569","name":"Consortium canadien en neurod\u00e9g\u00e9n\u00e9rescence associ\u00e9e au vieillissement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>At the end of life, changing healthcare needs may lead to decreased use of preventive therapies and increased use of medications for symptom management. This study compared polypharmacy, hyperpolypharmacy, and medication-dispensing patterns among community-dwelling older adults with dementia, community-dwelling older adults without dementia, and older adults with dementia in long-term care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We completed a retrospective, matched case-control study using linked administrative health data from Nova Scotia, Canada. We compared polypharmacy, hyperpolypharmacy, and medications dispensed among three groups (community-dwelling older adults with dementia, community-dwelling older adults without dementia, and older adults with dementia in long-term care). We chose community-dwelling older adults with dementia with dates of death between 1 January 2019 and 1 January 2021, and then matched with replacement to community-dwelling older adults without dementia and older adults with dementia in long-term care based on age, administrative sex, and date of death \u00b130 days. Descriptive comparisons of polypharmacy, hyperpolypharmacy, and medications used during each of three equal periods of the last year of life (early, mid, and late) were made. Logistic regression was used to estimate the probability of polypharmacy and hyperpolypharmacy, adjusting for demographic and clinical factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Each group included 1274 individuals. The mean age was 84.8 years. Overall, 50.9% (1944\/3822) experienced polypharmacy and 8.7% (332\/3822) hyperpolypharmacy, with community-dwelling older adults with dementia consistently having the highest rates. The most common medications dispensed in the last year of life were furosemide, levothyroxine sodium, salbutamol, and vitamin B12.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Community-dwelling older adults with dementia had the highest rates of polypharmacy and hyperpolypharmacy across all time periods assessed. Medications most frequently dispensed in the last year of life did not change in ways that would be expected if deprescribing recommendations were being followed. This suggests that prescribing and deprescribing at the end of life are potential areas for pharmacist support and involvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/03000605261487270","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:02:00Z","timestamp":1790564520000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Polypharmacy and patterns of medication use in the final year of life among people living with dementia in Canada: A case-control study"],"prefix":"10.1177","volume":"54","author":[{"given":"Jasmine","family":"Mah","sequence":"first","affiliation":[{"name":"Nova Scotia Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Richer","sequence":"additional","affiliation":[{"name":"McGill University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Emdin","sequence":"additional","affiliation":[{"name":"University of Toronto"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-995X","authenticated-orcid":false,"given":"Kenneth","family":"Rockwood","sequence":"additional","affiliation":[{"name":"Nova Scotia Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6299-7967","authenticated-orcid":false,"given":"Samuel","family":"Stewart","sequence":"additional","affiliation":[{"name":"Dalhousie University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7514-8972","authenticated-orcid":false,"given":"Melissa K","family":"Andrew","sequence":"additional","affiliation":[{"name":"Dalhousie University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7982-4437","authenticated-orcid":false,"given":"Shanna C","family":"Trenaman","sequence":"additional","affiliation":[{"name":"Dalhousie University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,9,27]]},"reference":[{"key":"e_1_3_3_2_2","unstructured":"Landmark-Study-Report-1-Path_Alzheimer-Society-Canada.pdf https:\/\/alzheimer.ca\/sites\/default\/files\/documents\/Landmark-Study-Report-1-Path_Alzheimer-Society-Canada.pdf (2022 accessed 9 December 2022)."},{"key":"e_1_3_3_3_2","article-title":"Dementia wellbeing and COVID-19: review and expert consensus on current research and knowledge gaps","author":"Liu KY","unstructured":"Liu KY, Howard R, Banerjee S, et al. Dementia wellbeing and COVID-19: review and expert consensus on current research and knowledge gaps. Int J Geriatr Psychiatry 2021; 36: 1597\u20131639.","journal-title":"Int J Geriatr Psychiatry 2021; 36: 1597\u20131639."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30403-4"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2021.05.012"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16394"},{"key":"e_1_3_3_7_2","article-title":"Emergency department utilisation and related costs in people with and without dementia in their last years of life","volume":"38","author":"Balasooriya NN","year":"2026","unstructured":"Balasooriya NN, Dao-Tran T-H, Batchelor F, et al. Emergency department utilisation and related costs in people with and without dementia in their last years of life. Emerg Med Australas EMA 2026; 38: e70258.","journal-title":"Emerg Med Australas EMA"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209925"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2019.10.022"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-017-0621-2"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-151177"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-240575"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2021.104459"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glag176"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2004.52250.x"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2016.09.003"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1177\/1715163517701770"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/imj.14804"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-91038-8_4"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2015.07.015"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2016.06.011"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02721-1"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14844"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2017.02.021"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2017.06.2267"},{"key":"e_1_3_3_26_2","unstructured":"Government of Canada SC. Profile table Census profile 2021 Census of Population-Nova Scotia [Province] https:\/\/www12.statcan.gc.ca\/census-recensement\/2021\/dp-pd\/prof\/index.cfm?Lang=E (2022 accessed 20 October 2024)."},{"key":"e_1_3_3_27_2","unstructured":"MSI Health Information Department Medavie Bluecross for Nova Scotia Department of Health and Wellness. Medical services insurance hi10 -annual statistical tables https:\/\/novascotia.ca\/dhw\/publications\/annual-statistical-reports\/dhw-annual-stats-report-msi-2024-25.pdf (2025 accessed 17 September 2026)."},{"key":"e_1_3_3_28_2","unstructured":"Towards understanding a dementia strategy for Nova Scotia https:\/\/novascotia.ca\/dhw\/dementia\/Dementia-Report-2015.pdf (2015 accessed 15 April 2025)."},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-025-13020-0"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1177\/13591053251341188"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/clc.70195"},{"key":"e_1_3_3_33_2","article-title":"Male and female drug prescription patterns and adverse drug reactions in chronic kidney disease","author":"Laville SM","unstructured":"Laville SM, Mouheb A, Massy ZA, et al. Male and female drug prescription patterns and adverse drug reactions in chronic kidney disease. Nephrol Dial Transplant 2025; 40: 2379\u20132389.","journal-title":"Nephrol Dial Transplant 2025;"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1571718"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-70628-8"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-025-01330-x"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1289"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2553813"},{"key":"e_1_3_3_39_2","unstructured":"Canadian Institute for Health Information. Changes in drug prescribing to seniors in Canada www.cihi.ca\/en\/changes-in-drug-prescribing-to-seniors-in-canada (2022 accessed 5 June 2024)."},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-025-02001-2"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1221069"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1177\/02692163211045917"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1532-5415.2003.51157.x"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1148-x"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269216320911596"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2019-002101"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1921"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.17493"},{"key":"e_1_3_3_49_2","first-page":"24","article-title":"Trazodone for insomnia: a systematic review","volume":"14","author":"Jaffer KY","year":"2017","unstructured":"Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: a systematic review. Innov Clin Neurosci 2017; 14: 24\u201334.","journal-title":"Innov Clin Neurosci"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2023.2214316"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/gps.70009"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-025-01196-3"},{"key":"e_1_3_3_53_2","unstructured":"Deprescribing guidelines and algorithms. Deprescribing.org https:\/\/deprescribing.org\/resources\/deprescribing-guidelines-algorithms\/ (accessed 18 June 2025)."},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(26)00519-2"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2023.111788"},{"key":"e_1_3_3_56_2","article-title":"High burden of polypharmacy and comorbidity in persons with psoriatic arthritis: an analysis of claims data, stratified by age and sex","author":"Albrecht K","unstructured":"Albrecht K, Regierer AC, Strangfeld A, et al. High burden of polypharmacy and comorbidity in persons with psoriatic arthritis: an analysis of claims data, stratified by age and sex. RMD Open 2023; 9: e002960.","journal-title":"RMD Open"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2025.06.012"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-023-04353-8"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2018.02.011"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gerinurse.2024.10.023"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjco.2024.09.008"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.19093"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06185-3"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25137286"},{"key":"e_1_3_3_65_2","article-title":"Effects of long-term proton pump inhibitor use on Serum electrolytes and vitamin levels: a quasi-experimental study in Pakistan","volume":"17","author":"Khan A","year":"2025","unstructured":"Khan A, Hussain M, Ahmed A, et al. Effects of long-term proton pump inhibitor use on Serum electrolytes and vitamin levels: a quasi-experimental study in Pakistan. Cureus 2025; 17: e82102.","journal-title":"Cureus"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12082910"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(00)00340-1"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40801-017-0121-x"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2025.106077"},{"key":"e_1_3_3_70_2","first-page":"354","article-title":"Deprescribing proton pump inhibitors: evidence-based clinical practice guideline","volume":"63","author":"Farrell B","year":"2017","unstructured":"Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician 2017; 63: 354\u2013364.","journal-title":"Can Fam Physician"},{"key":"e_1_3_3_71_2","unstructured":"Thompson W Barry A McCarthy L et al. Deprescribing statins for older persons: an evidence-based clinical practice guideline OSF https:\/\/osf.io\/uarnc\/overview (2025 accessed 6 August 2026)."},{"key":"e_1_3_3_72_2","first-page":"832","article-title":"Deprescribing antihyperglycemic agents in older persons: evidence-based clinical practice guideline","volume":"63","author":"Farrell B","year":"2017","unstructured":"Farrell B, Black C, Thompson W, et al. Deprescribing antihyperglycemic agents in older persons: evidence-based clinical practice guideline. Can Fam Physician 2017; 63: 832\u2013843.","journal-title":"Can Fam Physician"},{"key":"e_1_3_3_73_2","unstructured":"Canadian Agency for Drugs and Technologies in Health. Management of diabetes in the long-term care population: a review of guidelines. Ottawa ON: Canadian Agency for Drugs and Technologies in Health 2013."},{"key":"e_1_3_3_74_2","first-page":"600","article-title":"STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation","volume":"46","author":"Lavan AH","year":"2017","unstructured":"Lavan AH, Gallagher P, Parsons C, et al. STOPPFrail (Screening Tool of Older Persons Prescriptions in Frail adults with limited life expectancy): consensus validation. Age Ageing 2017; 46: 600\u2013607.","journal-title":"Age Ageing"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605261487270","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03000605261487270","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605261487270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:32:48Z","timestamp":1790861568000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03000605261487270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1177\/03000605261487270"],"URL":"https:\/\/doi.org\/10.1177\/03000605261487270","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"article-number":"03000605261487270"}}